Researchers are pushing the boundaries of noninvasive glucose monitoring—by looking to the brain. In this episode, I speak with Dr. Casey Halpern, founder and CEO of SynchNeuro, a startup developing a small wearable that sits behind the ear and reads brainwave activity (EEG) to track glucose levels. The device interprets electrical signals from the hypothalamus and other brain regions to detect shifts in glucose, stress, and metabolism in real time. Early testing suggests accuracy close to today’s CGMs—but without the needle. Dr. Halpern shares how this technology works, what’s next in development, and why brain-based monitoring could redefine the future of wearable health tech.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.